Pharmacogenomics is the study of how genes affect a person’s response to drugs. This relatively new field combines pharmacology and genomics to develop effective, safe medications and doses that will be tailored to a person’s genetic makeup.

Many drugs that are currently available are “one size fits all,” but they don't work the same way for everyone. It is difficult to predict how a drug behaves among different individuals. Adverse drug reactions are a significant cause of hospitalizations and deaths in many countries. With the knowledge gained from the human genome project, scientists are learning how the genes in human body react to the medications administered. These differential behavior in the genes is analyzed to know the effectiveness of the drug molecules in an individual and how it can be altered to make it more effective for an individual.

  • Challenges to pharmacogenomics
  • Toxicogenomics
  • Cancer pharmacogenomics
  • Translational pharmacogenomics
  • Nutrigenomics
  • Biomarker translation and testing
  • Molecular-targeted interventions including gene therapy
  • Biomarker translation and testing

Related Conference of Pharmacogenomics

Pharmacogenomics Conference Speakers